The rapid evolution of treatment strategies for hepatitis C.
about
Hepatitis C virus: A time for decisions. Who should be treated and when?New treatment strategies for hepatitis C infectionChronic inflammation and the role for cofactors (hepatitis C, drug abuse, antiretroviral drug toxicity, aging) in HAND persistenceHIV and hepatitis C virus infection in the United States: whom and how to testEnhancing our understanding of current therapies for hepatitis C virus (HCV)Hepatitis C in Egypt - past, present, and futureAssociation of Baseline Sleep Quality With Trajectories of Depressive Symptoms in Patients Undergoing Interferon TreatmentPreference, acceptability and implications of the rapid hepatitis C screening test among high-risk young people who inject drugs.Assessment of the Relation Between SNP in MxA Gene and the Responsiveness of Egyptian HCV Genotype 4 Patients to Pegylated Interferon and Ribavirin TreatmentHIV and hepatitis C co-infection in Europe, Israel and Argentina: a EuroSIDA perspective.LRRFIP1 Inhibits Hepatitis C Virus Replication by Inducing Type I Interferon in HepatocytesA Multiantigenic DNA Vaccine That Induces Broad Hepatitis C Virus-Specific T-Cell Responses in MiceImpact of Safety-Related Dose Reductions or Discontinuations on Sustained Virologic Response in HCV-Infected Patients: Results from the GUARD-C Cohort.Limited Generalizability of Registration Trials in Hepatitis C: A Nationwide Cohort Study.Health state utilities associated with attributes of treatments for hepatitis C.Proteasome- and ethanol-dependent regulation of HCV-infection pathogenesisA meta-analysis platform methodology for determining the comparative effectiveness of antihepatitis C virus regimens.Outcomes, costs and cost-effectiveness of treating hepatitis C with direct acting antivirals.Development of antiviral drugs for the treatment of hepatitis C at an accelerating pace.Managing drug-drug interactions with new direct-acting antiviral agents in chronic hepatitis C.Potential Liver Transplant Recipients with Hepatitis C: Should They Be Treated Before or After Transplantation?Cost-Effectiveness of the Hepatitis C Self-Management Program.Direct-acting antiviral agent efficacy and safety in renal transplant recipients with chronic hepatitis C virus infection: A PRISMA-compliant study.Successful Treatment of Hepatitis C in Renal Transplant Recipients With Direct-Acting Antiviral Agents.Successful Treatment of a Hepatitis C-Positive Patient Who Received Kidney Transplant From a Hepatitis C-Positive Donor: A Case Report.Genome-wide analysis for identification of adaptive diversification between hepatitis C virus subtypes 1a and 1b.Increased risk organ transplantation in the pediatric population.The 3rd Canadian Symposium on Hepatitis C Virus: expanding care in the interferon-free era.How much management is necessary? Sustaining the benefit of achieving a sustained virologic response to hepatitis C.Treatment strategy for hepatitis C: a dilemma for the payers and the providers.A Public Health Analysis on Gaps in Disease Monitoring and Opportunities for Improved Care for the Management of Hepatitis B and C.Novel patient-reported outcomes (PROs) used in a pilot and feasibility study of a Cognitive Behavioral Coping Skills (CBCS) group intervention for patients with chronic hepatitis C.Highlights from the 3rd international HIV/viral hepatitis Co-infection meeting - HIV/viral hepatitis: improving diagnosis, antiviral therapy and access
P2860
Q26768274-6BE64CA7-7D67-44E5-BFEE-66FF200BEE11Q26795407-FB1A7915-1D6C-4E7B-89FB-1AEC28AE6A92Q26825762-4C0A7B42-C106-4871-AC1D-FA81BBE48B33Q26996736-9BF99630-65E6-47A0-9A00-30F03423176CQ28085718-02C0672A-7023-4F7E-80C5-7EF7A15646B8Q28354329-73AE5BA6-2A11-47A2-8BF1-814E4AEAE400Q28387292-A47F586D-6A12-4A41-8010-DE4C770CBE48Q31168171-429A3C94-92E0-40C1-B9FF-2438E198B52AQ33625258-655D22DF-D87A-47F9-B6EC-8446F768E1D0Q34260569-AFE54EF4-237F-41D6-9EFF-7E5F6C8EDE07Q35671655-133BBD57-922C-419F-9E46-32D7118C1B7CQ35861251-07DA2329-F7B8-4F4F-B18C-EB5B7524B976Q35971413-EE181E60-C7AF-4C3A-8459-9C2F5B956F13Q36123998-0C4376A1-DEBA-4D7F-A8FC-005BCBBDA6F0Q36285092-72A6D48A-5EA1-41C0-A794-E08F206D715AQ38255471-EA92FC12-F350-473F-BDB7-42509E52B6EAQ38397145-F5A21722-336A-4E54-AC70-BCD163FA4C91Q38470584-CC9AE670-ED84-481A-8FB2-B9E7E82F6BDCQ38515906-CC7F980F-AF07-41EC-8D48-F922A9355808Q38929010-D2F5BA2A-5381-4933-BE30-09D9814E569CQ39203624-CAD198F3-08A4-4C20-8C39-D3CB16127B8CQ39749160-406A073E-AB94-4B9E-A361-17D3822E9950Q40107697-3792E913-86B9-4A71-AA1A-01A307FD7BAFQ40278284-4FCFCEDA-75B8-4688-AFC6-0248FAF0EFD6Q40551119-69AD9A0A-DCF5-40F8-81F2-3DE593DF00BEQ40711741-A95DDD7F-9955-4750-80CD-D950A2AA18F2Q41935477-32FC1DC8-8870-4914-83A1-61C31D298632Q42955909-425B0EE2-D6CB-4C1E-9374-4888C09C58F7Q44602225-B191CE54-574B-4B07-9014-809BC015AF61Q47777442-099D3EE1-73D8-47A4-A259-42F8778E21C6Q52645814-9A0A203F-2E1D-4477-ABE4-3ABA68D657EAQ55505674-3F368E23-7EC0-4B9D-88BB-D25AF3A72BF4Q58862428-D6420894-09FD-4E0F-8663-51EC7B67D7A4
P2860
The rapid evolution of treatment strategies for hepatitis C.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The rapid evolution of treatment strategies for hepatitis C.
@en
type
label
The rapid evolution of treatment strategies for hepatitis C.
@en
prefLabel
The rapid evolution of treatment strategies for hepatitis C.
@en
P2860
P356
P1476
The rapid evolution of treatment strategies for hepatitis C.
@en
P2093
Andrew J Muir
P2860
P304
628-35; quiz 636
P356
10.1038/AJG.2014.66
P407
P577
2014-04-15T00:00:00Z